New vaccine aims to stop rare but deadly brain infections
NCT ID NCT06899802
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a new vaccine designed to protect healthy adults from two rare but serious mosquito-borne viruses that can cause brain swelling (encephalitis). The trial involves 411 participants and aims to find the best dose and schedule for the vaccine. Researchers will measure the body's immune response and monitor for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research
Sacramento, California, 95864, United States
-
Benchmark Research
Kenner, Louisiana, 70065, United States
-
Benchmark Research
San Angelo, Texas, 76904, United States
-
Clay-Platte Family Medicine, P.C./CCT Research
Kansas City, Missouri, 64151, United States
-
Jefferson City Medical Group / Avacare
Jefferson City, Missouri, 65109, United States
-
Johnson County Clin-Trials
Lenexa, Kansas, 66219, United States
-
Lifeline Primary Care, Inc. / CCT Research
Lilburn, Georgia, 30047, United States
-
Papillion Research Center/CCT Research
Papillion, Nebraska, 68046, United States
-
Versailles Family Medicine, PLLC/CCT Research
Versailles, Kentucky, 40383, United States
Conditions
Explore the condition pages connected to this study.